Secondary Prevention of Bone Disease in Men on Androgen Deprivation Therapy for Prostate Cancer: Quality Improvement Through Implementation of Evidence-Based Bone Health Guidelines
Identification:
unj_ma19_01
Issue:
March-April 2019
Volume:
Volume 39 Number 2
Credits(Post Test and/or Evaluation Required) Available until 04/30/2021
Contact hours available until 4/30/2021. Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation. Faculty, Planners and Authors Conflict of Interest Disclosure: The author(s), editor, editorial board, content reviewers, and education director reported no actual or potential conflict of interest in relation to this continuing nursing education article. Commercial Support and Sponsorship: No commercial support or sponsorship declared. Accreditation Statement: This educational activity is provided by the Society of Urologic Nurses and Associates (SUNA).
SUNA is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
SUNA is a provider approved by the California Board of Registered Nursing, provider number CEP 5556. Licensees in the state of California must retain this certificate for four years after the CNE activity is completed.
This article was reviewed and formatted for contact hour credit by Michele Boyd, MSN, RN-BC, SUNA Education Director. Learning Outcome: After completing this continuing nursing education activity, the learner will be able to identify best practices using evidence-based guidelines to develop a bone health protocol for men being treated with androgen deprivation therapy (ADT) for prostate cancer. Learner Engagement Activity: Identify the strengths and limitations of the Quality Improvement Process with Plan-Do-Study-Act (PDSA) cycles used to implement the bone health protocol described in this article.